Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd.

CANF
Can-Fite BioPharma Ltd.US flagNew York Stock Exchange American
3.38
USD
+0.07
- -
1.82MMarket Cap

Can-Fite BioPharma Ltd. (CANF) Stock Split History

Learn about Can-Fite BioPharma Ltd.'s most recent 1-for-20 basis stock split on January 05, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Can-Fite BioPharma Ltd.'s most recent stock split

Split Date: 2026-01-05
Split Ratio: 1:20
Price Before Split: $0.21
Price After Split: $0.01

Developer API

Get CANF split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/CANF

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Can-Fite BioPharma Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-01-051:20Yes$0.21$0.01
2023-01-091:10Yes$0.03$0.00
2019-05-101:15Yes$0.02$0.00

About Can-Fite BioPharma Ltd.

Company overview and industry information

Can-Fite BioPharma Ltd. (CANF) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Can-Fite BioPharma Ltd. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.